Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'gambogic acid 20172'

Search results for: 'gambogic acid 20172'

Items 11-20 of 44

Page
per page
  1. WY-14643 (Pirinixic Acid)
    A4305 WY-14643 (Pirinixic Acid)
     1 Citation
    Target: PPAR
    Summary: PPARα agonist,selective and highly potent
      insoluble in H2O; ≥16.2 mg/mL
  2. Valproic acid sodium salt (Sodium valproate)
    A4099 Valproic acid sodium salt (Sodium valproate)
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      ≥8.35 mg/mL
  3. Vorinostat (SAHA, MK0683)
    A4084 Vorinostat (SAHA, MK0683)
     9 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      insoluble in EtOH; insoluble in H2O; ≥4.41 mg/mL
  4. Nonivamide (Capsaicin Analog)
    A3278 Nonivamide (Capsaicin Analog)
     1 Citation
    Target: TRP Channel
    Summary: TRPV1 receptor agonist
      insoluble in H2O; ≥15.27 mg/mL
  5. Calcium Levofolinate
    B1688 Calcium Levofolinate
    Summary: Calcium salt of folinic acid
  6. Palovarotene
    B1175 Palovarotene
    Target: RARs
    Summary: Selective retinoic acid receptor gamma(RAR-γ) agonist
      ≥41.5 mg/mL
  7. PF-3845
    A4374 PF-3845
     1 Citation
    Target: FAAH
    Summary: FAAH ihibitor,highly potent and selective
      Soluble in DMSO
  8. Tretinoin (Aberela)
    A8539 Tretinoin (Aberela)
    Target: RAR/RXR
    Summary: retinoic acid, treats acne vulgaris and keratosis pilaris
      insoluble in H2O; ≥11.9 mg/mL
  9. AM966
    A3170 AM966
     2 Citation
    Target: LPA Receptors
    Summary: LPA1 antagonist, oral active, high affinity, selective,
      ≥24.55 mg/mL
  10. TAK-875
    A8339 TAK-875
    Target: GPR40
    Summary: GPR40 agonist
      ≥26.25 mg/mL

Items 11-20 of 44

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
  2. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 39item
  2. Natural Products 3item
Reversibility
  1. Reversible 5item
  2. Irreversible 1 item
Target
  1. Proteasome 1 item
  2. Histone Deacetylases (HDACs) 4item
  3. Aurora Kinases 1 item
  4. CSF-1R 1 item
  5. Farnesoid X receptors (FXRs) 1 item
  6. LPA Receptors 2item
  7. DOT1L 1 item
  8. Nrf2 1 item
  9. Glucagon-like peptide 1 (GLP-1) receptors 1 item
  10. Neuraminidases (NA) 1 item
  11. RARs 4item
  12. FAK 3item
  13. CREBBP 1 item
  14. EP300 1 item
  15. Pyk2 3item
  16. Calcium ionophores 1 item
  17. Insulin and Insulin-like Receptors 1 item
  18. AdipoR2 1 item
  19. Fatty-acid-binding proteins (FABPs) 1 item
  20. Free Fatty Acid Receptors 2item
  21. Farnesyl Diphosphate Synthases 1 item
  22. Calcium-activated chloride channels (CaCC) 1 item
  23. GPR35 1 item
  24. NPY Receptors 1 item
  25. RAR/RXR 1 item
  26. Opioid receptors 1 item
  27. Histamine H2 Receptors 1 item
  28. TRP Channel 1 item
  29. Xanthine oxidoreductases 1 item
  30. fibrinolysis 1 item
  31. GPR40 1 item
  32. PPAR 1 item
  33. HCV polymerase 1 item
  34. FAAH 1 item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 1 item
  3. Bladder Cancer 1 item
  4. Brain Injuries Studies 1 item
  5. Breast Cancer 7item
  6. Cancer 22item
  7. Colon Cancer 2item
  8. Colorectal Cancer 3item
  9. Epilepsy 1 item
  10. Glioblastoma 1 item
  11. Glioma 2item
  12. Hepatitis C 1 item
  13. Hepatocellular Carcinoma 3item
  14. HIV Infections 2item
  15. Inflammation 1 item
  16. Inflammatory Diseases 1 item
  17. Influenza 1 item
  18. Lymphoma 1 item
  19. Melanoma 1 item
  20. Mixed Lineage Leukemia 1 item
  21. Multiple Myeloma 1 item
  22. Myeloma 1 item
  23. Non-small Cell Lung Cancer 1 item
  24. Ovarian Cancer 1 item
  25. Pain Relief 1 item
  26. Pancreatic Cancer 7item
  27. Prostate Cancer 4item
  28. Renal Cancer 1 item
  29. Renal Cell Carcinoma 2item
  30. Type 2 Diabetes 5item